Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / puma biotechnology a story in flux heading into mid

PBYI - Puma Biotechnology: A Story In Flux Heading Into Mid-2024

Puma Biotechnology Inc

2024-05-05 04:02:32 ET

Summary

  • Puma Biotechnology's pipeline is evolving, but analysts express "Hold" sentiments due to its stagnant pipeline over the past few years.
  • The company's lone approved product, neratinib, is being marketed for HER2-positive breast cancer, but competition in the HER2 space is fierce.
  • Puma Biotechnology's future outlook remains uncertain, with the success of its pipeline projects, particularly alisertib, being highly risky.

...

For further details see:

Puma Biotechnology: A Story In Flux Heading Into Mid-2024
Stock Information
Company Name: Puma Biotechnology Inc
Stock Symbol: PBYI
Market: NASDAQ
Website: pumabiotechnology.com
Menu
PBYI PBYI Quote PBYI Short PBYI News PBYI Articles PBYI Message Board
Get PBYI Alerts

News, Short Squeeze, Breakout and More Instantly...